Penile cancer is a rare tumor. There is a limited understanding of the biological mediators of prognostic and therapeutic importance in penile cancer. However, there exists some fundamental understanding of the major pathways involved in the development of penile pre-neoplastic lesions and neoplasms. The aim of the present review is to highlight our current state of molecular knowledge in penile cancer to foster the necessary tools for researchers to pave major advancements in our current treatment paradigms and cancer specific outcomes
OBJECTIVE: No substantial improvement in overall survival has been obtained over the past two decade...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
Penile carcinoma (PeCa) represents an important public health problem in poor and developing countri...
Abstract: Penile cancer is a rare tumor. There is a limited understanding of the biological mediator...
Penile cancer (PeCa) is a rare malignancy with potentially devastating effects. Squamous cell carcin...
Penile cancer (PeCa) is a rare malignancy with potentially devastating effects. Squamous cell carcin...
Penile carcinoma is a rare, male cancer. Although the incidence of penile carcinoma is very low in W...
PURPOSE OF REVIEW: To provide a comprehensive summary of risk factors, molecular machinery as well a...
Review on Penile tumors: an overview, with data on clinics, and the genes involved
Current chemotherapeutic treatment for advanced penile squamous cell carcinoma has substantial side ...
Penile cancer is a disease with a high morbidity and mortality. Its prevalence is relatively rare, b...
This review highlights the significant advances made in the diagno-sis and management of penile canc...
Penile squamous cell carcinoma (PSCC) is a rare but aggressive neoplasm with dual pathogenesis (huma...
Penile cancer is introduced in chapter 1. Chapter 2 and 3 describe immunohistochemical studies. ...
Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is bas...
OBJECTIVE: No substantial improvement in overall survival has been obtained over the past two decade...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
Penile carcinoma (PeCa) represents an important public health problem in poor and developing countri...
Abstract: Penile cancer is a rare tumor. There is a limited understanding of the biological mediator...
Penile cancer (PeCa) is a rare malignancy with potentially devastating effects. Squamous cell carcin...
Penile cancer (PeCa) is a rare malignancy with potentially devastating effects. Squamous cell carcin...
Penile carcinoma is a rare, male cancer. Although the incidence of penile carcinoma is very low in W...
PURPOSE OF REVIEW: To provide a comprehensive summary of risk factors, molecular machinery as well a...
Review on Penile tumors: an overview, with data on clinics, and the genes involved
Current chemotherapeutic treatment for advanced penile squamous cell carcinoma has substantial side ...
Penile cancer is a disease with a high morbidity and mortality. Its prevalence is relatively rare, b...
This review highlights the significant advances made in the diagno-sis and management of penile canc...
Penile squamous cell carcinoma (PSCC) is a rare but aggressive neoplasm with dual pathogenesis (huma...
Penile cancer is introduced in chapter 1. Chapter 2 and 3 describe immunohistochemical studies. ...
Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is bas...
OBJECTIVE: No substantial improvement in overall survival has been obtained over the past two decade...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
Penile carcinoma (PeCa) represents an important public health problem in poor and developing countri...